[{"NetIncomeLoss_1_Q2_USD":-36692000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":9823000.0,"DueFromRelatedPartiesCurrent_0_Q2_USD":3586000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"AccruedLiabilitiesCurrent_0_Q2_USD":31891000.0,"ContractWithCustomerAssetNetCurrent_0_Q2_USD":0.0,"OperatingLeasesRentExpenseNet_2_Q2_USD":1100000.0,"OperatingLeasesRentExpenseNet_1_Q2_USD":500000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":5000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-145880000.0,"Depreciation_1_Q2_USD":1600000.0,"Depreciation_2_Q2_USD":3118000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":10000.0,"AccruedLiabilitiesCurrentAndNoncurrent_0_Q2_USD":31891000.0,"InterestIncomeExpenseNonoperatingNet_2_Q2_USD":229000.0,"InterestIncomeExpenseNonoperatingNet_1_Q2_USD":115000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":12000.0,"AssetsCurrent_0_Q2_USD":403129000.0,"OtherNoncashIncomeExpense_2_Q2_USD":-49000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":11338838.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":1905000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2_Q2_USD":1000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q2_USD":23000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_0_Q2_security":11.0,"CommonStockSharesIssued_0_Q2_shares":77307156.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":377728000.0,"IncreaseDecreaseInAccountsReceivableRelatedParties_2_Q2_USD":3253000.0,"Assets_0_Q2_USD":423011000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":18544000.0,"ShareBasedCompensation_2_Q2_USD":13298000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":11.97,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":4963000.0,"ShortTermInvestments_0_Q2_USD":291147000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":84269000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":43570000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":15.55,"EarningsPerShareBasic_1_Q2_USD":-0.48,"EarningsPerShareBasic_2_Q2_USD":-0.84,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":76568217.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":77096416.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":0.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-187000.0,"CommonStockValue_0_Q2_USD":77000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_0_Q2_USD":74692000.0,"IncreaseDecreaseInPrepaidRent_2_Q2_USD":1451000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":143801000.0,"PaymentsOfStockIssuanceCosts_2_Q2_USD":0.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":50000000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q2_USD":390600000.0,"OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_0_Q2_USD":2607000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-64235000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-36669000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-4522000.0,"OtherAssetsNoncurrent_0_Q2_USD":5593000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":99403000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":735860000.0,"Liabilities_0_Q2_USD":49936000.0,"RevenueFromRelatedParties_1_Q2_USD":16800000.0,"DeferredRentCreditCurrent_0_Q2_USD":3048000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q2_shares":32546348.0,"StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_0_Q2_shares":657.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"EarningsPerShareDiluted_1_Q2_USD":-0.48,"EarningsPerShareDiluted_2_Q2_USD":-0.84,"RestrictedCashNoncurrent_0_Q2_USD":1499000.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":194525000.0,"OperatingLeasesFutureMinimumPaymentsDueInTwoYears_0_Q2_USD":5455000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":37237000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":17000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":6716000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-45535000.0,"StockIssuedDuringPeriodValueEmployeeBenefitPlan_1_Q2_USD":125000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":76568217.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":77096416.0,"LiabilitiesCurrent_0_Q2_USD":45043000.0,"AccountsPayableCurrent_0_Q2_USD":5141000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":100902000.0,"IncreaseDecreaseInContractWithCustomerAsset_2_Q2_USD":-1500000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_2_Q2_USD":1409000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":8993000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":7812000.0,"InterestBearingDepositsInBanks_0_Q2_USD":12800000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":1280194.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q2_USD":1409000.0,"NumberOfOperatingSegments_2_Q2_segment":1.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q2_USD":74290000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":12790000.0,"NetIncomeLoss_2_Q2_USD":-64236000.0,"CommonStockSharesOutstanding_0_Q2_shares":77307156.0,"PaymentsToAcquireMachineryAndEquipment_2_Q2_USD":1355000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-47614000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-362867000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":134580000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":19.23,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":3157000.0,"CommonStockSharesAuthorized_0_Q2_shares":400000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":38348000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":16773000.0,"OperatingIncomeLoss_2_Q2_USD":-64465000.0,"OperatingIncomeLoss_1_Q2_USD":-36620000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_2_Q2_USD":26700000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":4963000.0,"PreferredStockValue_0_Q2_USD":0.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":6.1,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q2_USD":23000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":423011000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":143000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":76000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":50027000.0,"OperatingExpenses_2_Q2_USD":102813000.0,"OperatingExpenses_1_Q2_USD":53393000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":2038000.0,"ProfitLoss_2_Q2_USD":-64236000.0,"StockholdersEquity_0_Q2_USD":373075000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":377723000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":-1518000.0,"DeferredRentCreditNoncurrent_0_Q2_USD":4893000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":11124234.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":8994528.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"OperatingLeasesFutureMinimumPaymentsDue_0_Q2_USD":13356000.0,"Ticker":"NGM","CIK":"1426332","name":"NGM BIOPHARMACEUTICALS INC","OfficialName":"NGM Biopharmaceuticals Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1227500649.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20210805"}]